Continued research is needed to identify the specific molecular mechanisms linking SMN deficiency to downstream target genes alteration and, secondarily, those genes’ relative contributions to the SMA phenotype in a mouse model of the disease. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.